×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
PharmaCyte Biotech (NASDAQ:PMCB) Stock Price Up 2%
Defense World
PharmaCyte Biotech, Inc. (NASDAQ:PMCB – Get Free Report)'s stock price traded up 2% during mid-day trading on Thursday .
3 hours ago
PharmaCyte Biotech's Diabetes Treatment: How Would It Work?
Yahoo Movies UK
SAN DIEGO, CA--(Marketwired - February 06, 2015) - PharmaCyte Biotech, Inc. (PMCB) -- How much would a cure for diabetes be worth?
2 days ago
PharmaCyte Biotech (NASDAQ:PMCB) Is In A Strong Position To Grow Its Business
Simply Wall Street
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price.
2 months ago
PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on ...
Herald Chronicle
LAS VEGAS--(BUSINESS WIRE)--May 21, 2024--. PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”), today announced a $7...
1 week ago
Femasys secures nearly $7M in funding from PharmaCyte
MassDevice
Femasys this week announced it received a strategic upfront investment of $6.85 million from biotech company PharmaCyte Biotech.
6 months ago
PharmaCyte Biotech Announces Final Results of Tender Offer
Yahoo Finance
LAS VEGAS, June 15, 2023--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) ("PharmaCyte" or the "Company") today announces the final results of its...
11 months ago
PharmaCyte Biotech Announces Cash Tender Offer for up to 7750000 Shares at $3.25 Per Share
Business Wire
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (Nasdaq: PMCB) (“PharmaCyte” or the “Company”) today announces a cash tender offer for...
12 months ago
MyMD Pharmaceuticals Secures Strategic Investments
citybiz
BALTIMORE–(BUSINESS WIRE)–MyMD Pharmaceuticals, Inc. (Nasdaq: MYMD), a clinical stage biopharmaceutical company committed to developing...
1 week ago
Troutman Pepper Advises PharmaCyte Biotech on Registered Direct Offering
Troutman Pepper
Troutman Pepper client PharmaCyte Biotech, Inc. (NASDAQ: PMCB) (PharmaCyte), a biotechnology company focused on developing cellular...
33 months ago
PharmaCyte Biotech Reaches Cooperation Agreement with Iroquois Capital
Business Wire
LAS VEGAS--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (NASDAQ: PMCB), a biotechnology company focused on developing cellular therapies for...
21 months ago